Markets & Regulations

(Image: Eastman Kodak)

Kodak Pharmaceuticals lands $765m US loan

By Jenni Spinner

The imaging company’s newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

(bennymarty/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

(HAKINMHAN/iStock via Getty Images Plus)

Latest FDA advice and actions on COVID-19

By Jenni Spinner

As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.

(gilz/iStock via Getty Images Plus)

Weekly FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

(April Thornberg/iStock via Getty Images Plus)

This week’s FDA COVID-19 news

By Jenni Spinner

The agency continues to offer advice for drug developers and other stakeholders, and to take action against companies that step out of line.

(Who_I_am/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues to issue advice, offer guidance and take action related to the virus behind the global pandemic.

(rudal30/iStock via Getty Images Plus)

FDA COVID-19 updates for the week

By Jenni Spinner

The federal agency continues to aid drug developers, trial teams and the public with advice and actions related to the virus behind the global pandemic.

(ChakisAtelier/iStock via Getty Images Plus)

Current FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice related to drug development and clinical research during the pandemic, and take action against those falling out of line.

(Nuthawut Somsuk/iStock via Getty Images Plus)

Newest FDA actions and alerts on COVID-19

By Jenni Spinner

The federal agency continues to monitor as the virus impacts the pharma and clinical trials industries, offering advice and taking action where necessary.

(elenabs/iStock via Getty Images Plus)

Latest FDA COVID-19 updates

By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

(zubada/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The agency continues to offer advice and take actions impacting the pharmaceutical and life-science industries during the pandemic.

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

(Image: Getty/zubada)

This week's FDA COVID-19 actions and advice

By Jenni Spinner

The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.

Follow us

Products

View more

Webinars